Ablynx N.V. | Key People and Executives
Olivier Brandicourt
Chief Executive Officer & Director
Christian Senectaire
Director
Christian Mulliez
Director
Emmanuel Babeau
Independent Director
Diane D. Souza
Independent Director
Bernard Charlès
Independent Director
Melanie Georgina Lee
Independent Director
Patrick Kron
Independent Director
Thomas C. Südhof
Independent Director
Fabienne Lecorvaisier
Independent Director
Suet-Fern Lee
Independent Director
Carole Piwnica
Independent Director
Claudie Haigneré
Independent Director
Olivier Brandicourt
Chief Executive Officer & Director
Jérôme Contamine
Chief Financial Officer & Executive VP-Finance
John C. Reed
Head-Global Research & Development
Ameet Nathwani
Executive Vice President-Medical Affairs
Dominique Carouge
Executive VP & Head-Business Transformation
Stefan Oelrich
Executive VP-Diabetes & Cardiovascular
Bill Sibold
Executive Vice President
Olivier Antoine M. Charmeil
EVP-General Medicines & Emerging Markets
Alan J. Main
Executive Vice President-Consumer Health Care
Muzammil M. Mansuri
Executive VP-Strategy & Business Development
Philippe Luscan
Executive Vice President-Global Industrial Affairs
Christian Senectaire
Director
Christian Mulliez
Director
Kathleen Tregoning
Executive Vice President-External Affairs
Jack Cox
Head-Global Media Relations
George Grofik
Head-Investor Relations
Roberto Pucci
Executive Vice President-Human Resources
Karen Linehan
Executive VP-Legal Affairs & General Counsel
Emmanuel Babeau
Independent Director
Diane D. Souza
Independent Director
Bernard Charlès
Independent Director
Melanie Georgina Lee
Independent Director
Patrick Kron
Independent Director
Thomas C. Südhof
Independent Director
Fabienne Lecorvaisier
Independent Director
Suet-Fern Lee
Independent Director
Carole Piwnica
Independent Director
Claudie Haigneré
Independent Director
| Address |
54, rue La Boétie
Paris Ile-de-France 75008
France
|
|
Employees
|
- |
| Website |
http://www.sanofi.com |
| Updated |
09/14/2018 |
| Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. |
